Laurus Labs vs Dr. Reddy’s: share price, P/E, ROE and financials compared
Laurus Labs
Dr. Reddy's Laboratories
Laurus Labs and Dr. Reddy’s at a glance
Laurus Labs and Dr. Reddy’s are both listed in Healthcare. Laurus Labs is the larger by market cap, at ₹1.3L Cr against ₹1.1L Cr for Dr. Reddy’s. On valuation, Dr. Reddy’s has the lower P/E (40.9× against 94.4×) and the lower price-to-book (2.96× against 20.86×). On returns and margins, Laurus Labs has the higher ROCE (19.5% against 14.2%), the higher ROE (24.0% against 7.3%) and the higher operating margin (30.4% against 15.9%). Over three years, Laurus Labs has faster 3-year profit growth (+4.0% against −1.7% a year), while Dr. Reddy’s has faster 3-year sales growth (+11.0% against +3.8% a year). Dr. Reddy’s carries less debt for its equity, with a debt-to-equity of 0.19× against 0.42×.
Key metrics, side by side
| Metric | Laurus LabsLAURUSLABS | Dr. Reddy’sDRREDDY |
|---|---|---|
| Price (₹) | 2,340.00 | 1,373.00 |
| Market cap (₹ Cr) | 1,26,433 | 1,14,462 |
| P/E | 94.4× | 40.9× (the lower figure, shaded) |
| P/B | 20.86× | 2.96× (the lower figure, shaded) |
| Dividend yield, trailing | 0.05% | 0.58% (the higher figure, shaded) |
| ROE | 24.0% (the higher figure, shaded) | 7.3% |
| ROCE | 19.5% (the higher figure, shaded) | 14.2% |
| Operating margin (OPM) | 30.4% (the higher figure, shaded) | 15.9% |
| Net margin (NPM) | 17.1% (the higher figure, shaded) | 8.5% |
| Sales CAGR 3Y | +3.8% | +11.0% (the higher figure, shaded) |
| Profit CAGR 3Y | +4.0% (the higher figure, shaded) | −1.7% |
| Debt to equity | 0.42× | 0.19× (the lower figure, shaded) |
| Interest cover | 8.3× | 15.7× (the higher figure, shaded) |
| Net profit TTM (₹ Cr) | 1,340 | 2,799 |
| 1Y return | +138.6% (the higher figure, shaded) | +13.8% |
| Promoter holding | 27.47% | 26.63% |
Laurus Labs vs Dr. Reddy’s: common questions
Which is bigger, Laurus Labs or Dr. Reddy’s?
By market cap, Laurus Labs is bigger at ₹1.3L Cr, against ₹1.1L Cr for Dr. Reddy’s (prices as of 6 Nov 2026). Net profit over the last twelve months was ₹1,340 Cr for Laurus Labs and ₹2,799 Cr for Dr. Reddy’s.
Which has a lower P/E ratio, Laurus Labs or Dr. Reddy’s?
Laurus Labs trades at a P/E of 94.4× and Dr. Reddy’s at 40.9×. Dr. Reddy’s has the lower P/E. P/E is the share price divided by earnings per share; it varies a lot between industries and with growth, so it says little on its own.
Which has a higher ROE, Laurus Labs or Dr. Reddy’s?
Laurus Labs reports a return on equity of 24.0% and Dr. Reddy’s 7.3%. Laurus Labs has the higher ROE. ROE is net profit as a share of shareholders’ equity.
Which is growing faster, Laurus Labs or Dr. Reddy’s?
Over the last three years: Sales grew +3.8% a year at Laurus Labs and +11.0% at Dr. Reddy’s, so Dr. Reddy’s grew sales faster; profit grew +4.0% a year at Laurus Labs and −1.7% at Dr. Reddy’s, so Laurus Labs grew profit faster. Past growth doesn’t predict future growth.